5 reports

FOUNDED IN 2001, IS TO PROVIDE DIAGNOSTIC SERVICES OUTSOURCING CORE BUSINESS OF INDEPENDENT THIRD PARTY MEDICAL DIAGNOSIS SERVICE, WITH " SERVICE + PRODUCT" WITH THE CHARACTERISTIC OF DIAN INTEGRATION BUSINESS MODEL BECOME THE INDUSTRY LEADER, AND IN JULY 2011, THE FIRST TO APPE

  • Cancer Diagnostic
  • China
  • Beijing Shimadzu Medical Equipment Co., Ltd.
  • GE Medical Systems Co., Ltd
  • Hitachi, Ltd.

FOUNDED IN 2001, IS TO PROVIDE DIAGNOSTIC SERVICES OUTSOURCING CORE BUSINESS OF INDEPENDENT THIRD PARTY MEDICAL DIAGNOSIS SERVICE, WITH " SERVICE + PRODUCT" WITH THE CHARACTERISTIC OF DIAN INTEGRATION BUSINESS MODEL BECOME THE INDUSTRY LEADER, AND IN JULY 2011, THE FIRST TO APPE

  • Cancer Diagnostic
  • China
  • Demand
  • Market Size
  • Hitachi, Ltd.

Moreover, enhancements of clinical development frameworks in these economies to enable clinical research outsourcing as an effect of the availability of target population is a growth rendering driver in this region.

  • Cancer Diagnostic
  • Diagnostics
  • Forecast

The UniCel DxI ## system is used primarily in mid-volume laboratories, making it possible for mid-sized hospitals to perform lower-volume assays in-house, reducing outsourcing costs and improving laboratory efficiency.

  • Cancer Diagnostic
  • RNA
  • Affymetrix, Inc.
  • QIAGEN N.V.
  • Roche Group

outsourcing core technologies to specialist service providers, reducing internal investment in discovery, and promoting strategic collaborations and acquisitions.

  • Cancer
  • Cancer Diagnostic
  • Clinical Trial
  • United States
  • GlobalData's company